Voriconazole | List of Frontiers open access articles

Review

Published on 06 Dec 2024

Voriconazole: a review of adjustment programs guided by therapeutic drug monitoring

in Pharmacology of Infectious Diseases

Li Jiang
Zhiqiang Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1439586

7,771 views
7 citations

Brief Research Report

Published on 15 Aug 2025

Plasma concentration of voriconazole under concomitant use of nirmatrelvir/ritonavir in patients with COVID-19: a multicenter retrospective study

in Drug Metabolism and Transport

Hao Shi
Xuan Zhang
Qihui Kong
Lingyan Yu
Zhenwei Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1654671

1,618 views
1 citation

Original Research

Published on 20 Aug 2024

Influence of C-reactive protein on the pharmacokinetics of voriconazole in relation to the CYP2C19 genotype: a population pharmacokinetics analysis

in Drug Metabolism and Transport

Jing Ling
Xuping Yang
Lulu Dong
Yan Jiang
Sulan Zou
Nan Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1455721

3,082 views
8 citations

Case Report

Published on 23 Apr 2021

Voriconazole Induced Hallucinations and Visual Disturbances in a Female Child: A Case Report and Literature Review

in Obstetric and Pediatric Pharmacology

Rujiang Zheng
Yu Li
Chuyi Guo
Yuxin Pei
Zhiyong Ke
Libin Huang

Frontiers in Pediatrics

doi 10.3389/fped.2021.655327

9,013 views
10 citations

Original Research

Published on 31 Mar 2020

A 23 bp cyp51A Promoter Deletion Associated With Voriconazole Resistance in Clinical and Environmental Isolates of Neocosmospora keratoplastica

in Antimicrobials, Resistance and Chemotherapy

Jasper Elvin James
Erwin Lamping
Jacinta Santhanam
Trudy Jane Milne
Mohd Fuat Abd Razak
Latiffah Zakaria
Richard David Cannon

Frontiers in Microbiology

doi 10.3389/fmicb.2020.00272

8,081 views
16 citations

Original Research

Published on 04 Jan 2024

Enhancing voriconazole therapy in liver dysfunction: exploring administration schemes and predictive factors for trough concentration and efficacy

in Drug Metabolism and Transport

Yichang Zhao
Huaiyuan Liu
Chenlin Xiao
Jingjing Hou
Bikui Zhang
Jiakai Li
Min Zhang
Yongfang Jiang
Indy Sandaradura
Xuansheng Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1323755

2,859 views
5 citations

Original Research

Published on 05 Jan 2026

Study on the correlation between plasma concentration of voriconazole and clinical efficacy and safety in elderly patients

in Pharmacology of Infectious Diseases

Yueran Li
Huifang Xu
Huifang Wang
Wen Zhang
Yujia Song
Sheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1726902

806 views

Case Report

Published on 05 Nov 2025

A case report of drug–drug interaction between voriconazole and simnotrelvir/ritonavir

in Antibiotics in Clinical Settings

Tingting Chen
Qingquan Zhang

Frontiers in Antibiotics

doi 10.3389/frabi.2025.1705987

1,420 views

Original Research

Published on 17 Aug 2022

Impact of extracorporeal membrane oxygenation on voriconazole plasma concentrations: A retrospective study

in Pharmacology of Infectious Diseases

Qinghua Ye
Xin Yu
Wenqian Chen
Min Li
Sichao Gu
Linna Huang
Qingyuan Zhan
Chen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.972585

4,965 views
28 citations

Case Report

Published on 27 Jun 2024

Case report: dose-dependent interaction between dexamethasone and voriconazole in severely ill patients with non-Hodgkin’s lymphoma being treated for invasive pulmonary aspergillosis

in Translational Pharmacology

Jingjing Huang
Yang Chen
Ming Zhong
Ruoming Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403966

2,388 views
4 citations

Case Report

Published on 07 Dec 2023

Myelodysplastic syndrome-like response after voriconazole treatment of systemic lupus erythematosus complicated with fungal infection: a case report

in Hematology

Guang-Liang Xie
Xiao-Su Wang
Ling-Yan Hu
Yi Wang
Xiangchen Gu
Yan-Qiu Xu

Frontiers in Medicine

doi 10.3389/fmed.2023.1286649

4,466 views
3 citations

Original Research

Published on 09 Apr 2025

Population pharmacokinetics and dose optimization of voriconazole in patients with COVID-19-associated pulmonary aspergillosis

in Pharmacology of Infectious Diseases

Hui Wang
Yue Shen
Xuemei Luo
Lu Jin
Huaijun Zhu
Jing Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1554370

2,347 views
5 citations

Original Research

Published on 03 Jan 2022

Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization

in Drug Metabolism and Transport

SiChan Li
SanLan Wu
WeiJing Gong
Peng Cao
Xin Chen
Wanyu Liu
Liping Xiang
Yang Wang
JianGeng Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.730826

5,015 views
11 citations

Original Research

Published on 21 May 2025

Efficacy and safety of voriconazole and caspofungin for the treatment of invasive pulmonary aspergillosis in critically ill patients in China

in Clinical Infectious Diseases

Zhuo Li
Yuan Zong
Dayu Chen
Juan Ma
Peng Zhang
Lu Cao

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1584950

3,659 views
3 citations

Original Research

Published on 10 Sep 2024

Individualized dosing parameters for tacrolimus in the presence of voriconazole: a real-world PopPK study

in Renal Pharmacology

Yi-Chang Zhao
Zhi-Hua Sun
Jia-Kai Li
Huai-Yuan Liu
Bi-Kui Zhang
Xu-Biao Xie
Chun-Hua Fang
Indy Sandaradura
Feng-Hua Peng
Miao Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1439232

2,682 views
4 citations

Original Research

Published on 26 Aug 2025

Risk factors for voriconazole-associated hepatotoxicity in patients with liver dysfunction: a retrospective nested case–control study

in Predictive Toxicology

Jing Ren
Xinfeng Cai
Wei Ge
Jinlin Guo
Shan Wang
Qinhui Wang
Linna Liu
Le Yang
Qi Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1625003

2,546 views

Articles

Voriconazole: a review of adjustment programs guided by therapeutic drug monitoring

Plasma concentration of voriconazole under concomitant use of nirmatrelvir/ritonavir in patients with COVID-19: a multicenter retrospective study

Influence of C-reactive protein on the pharmacokinetics of voriconazole in relation to the CYP2C19 genotype: a population pharmacokinetics analysis

Voriconazole Induced Hallucinations and Visual Disturbances in a Female Child: A Case Report and Literature Review

A 23 bp cyp51A Promoter Deletion Associated With Voriconazole Resistance in Clinical and Environmental Isolates of Neocosmospora keratoplastica

Enhancing voriconazole therapy in liver dysfunction: exploring administration schemes and predictive factors for trough concentration and efficacy

Study on the correlation between plasma concentration of voriconazole and clinical efficacy and safety in elderly patients

A case report of drug–drug interaction between voriconazole and simnotrelvir/ritonavir

Impact of extracorporeal membrane oxygenation on voriconazole plasma concentrations: A retrospective study

Case report: dose-dependent interaction between dexamethasone and voriconazole in severely ill patients with non-Hodgkin’s lymphoma being treated for invasive pulmonary aspergillosis

Myelodysplastic syndrome-like response after voriconazole treatment of systemic lupus erythematosus complicated with fungal infection: a case report

Population pharmacokinetics and dose optimization of voriconazole in patients with COVID-19-associated pulmonary aspergillosis

Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization

Efficacy and safety of voriconazole and caspofungin for the treatment of invasive pulmonary aspergillosis in critically ill patients in China

Individualized dosing parameters for tacrolimus in the presence of voriconazole: a real-world PopPK study

Risk factors for voriconazole-associated hepatotoxicity in patients with liver dysfunction: a retrospective nested case–control study